Home/Filings/4/0001415889-25-004607
4//SEC Filing

GOLL JOHN 4

Accession 0001415889-25-004607

CIK 0001671927other

Filed

Feb 18, 7:00 PM ET

Accepted

Feb 19, 4:19 PM ET

Size

8.1 KB

Accession

0001415889-25-004607

Insider Transaction Report

Form 4
Period: 2025-02-17
GOLL JOHN
SVP, FINANCE & CAO
Transactions
  • Award

    Employee Share Option (Right to Buy)

    2025-02-17+14,80214,802 total
    Exercise: $29.60Exp: 2035-02-16Ordinary Shares (14,802 underlying)
  • Award

    Restricted Share Units

    2025-02-17+5,4055,405 total
    Ordinary Shares (5,405 underlying)
Footnotes (3)
  • [F1]25% of the shares subject to the option award shall vest on February 17, 2026, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.
  • [F2]Each restricted share unit ("RSU") represents a contingent right to receive one ordinary share.
  • [F3]The RSUs vest in four equal annual installments beginning February 17, 2026, subject to the Reporting Person's continuous service through each such vesting date.

Issuer

Immunocore Holdings plc

CIK 0001671927

Entity typeother

Related Parties

1
  • filerCIK 0001779466

Filing Metadata

Form type
4
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 4:19 PM ET
Size
8.1 KB